High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
James A. Fagin(Memorial Sloan Kettering Cancer Center), H. Phillip Koeffler(Cedars-Sinai Medical Center)
Cited by 653
Related Papers
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
|New England Journal of Medicine|2013|825
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739
Molecular Cloning of Transferrin Receptor 2
|Journal of Biological Chemistry|1999|640